Moderna's clinical trial success sparks stock surge; US equities seen opening higher

1. 1US major indexes expected to open higher on Wednesday, digesting retail earnings and Moderna trial results after tech-led selloff the prior session
2. 2Moderna (MRNA) jumps more than 94% in premarket while Merck (MRK) rises 6.6%; both hit all primary endpoints in late-stage trial of combination therapy with Keytruda
3. 3Target (TGT) gains 0.5% on raised full-year revenue outlook; Lowe's (LOW) falls 2.3% after guiding full-year comparable sales growth to zero

Source Reuters · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →